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Abstract. 
 
Angiogenesis is characterized by distinct 
phenotypic changes in vascular endothelial cells (EC). 
Evidence is provided that the 
 
Hox D3
 
 homeobox gene 
mediates conversion of endothelium from the resting to 
the angiogenic/invasive state. Stimulation of EC with 
basic fibroblast growth factor (bFGF) resulted in in-
creased expression of 
 
Hox D3
 
, integrin 
 
a
 
v
 
b
 
3, and the 
urokinase plasminogen activator (uPA). 
 
Hox D3
 
 anti-
sense blocked the ability of bFGF to induce uPA and 
integrin 
 
a
 
v
 
b
 
3 expression, yet had no effect on EC cell 
proliferation or bFGF-mediated cyclin D1 expression. 
Expression of Hox D3, in the absence of bFGF, re-
sulted in enhanced expression of integrin 
 
a
 
v
 
b
 
3 and 
uPA. In fact, sustained expression of 
 
Hox D3
 
 in vivo on 
the chick chorioallantoic membrane retained EC in this 
invasive state and prevented vessel maturation leading 
to vascular malformations and endotheliomas. There-
fore, 
 
Hox D3
 
 regulates EC gene expression associated 
with the invasive stage of angiogenesis.
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1. 
 
Abbreviations used in this paper
 
: bFGF, basic fibroblast growth factor;
BM, basement membrane; CAM, chorioallantoic membrane; EC, vascular
endothelial cells; HUVEC, human umbilical vein endothelial cells; uPA,
urokinase plasminogen activator.
 
A
 
ngiogenesis 
 
requires coordinate changes in endo-
thelial cell morphology and gene expression. In
the resting vasculature, quiescent capillary endo-
thelial cells are in contact with a laminin-rich basement
membrane (BM)
 
1
 
 and are nonmigratory. In response to
angiogenic stimuli, including cytokines such as basic fibro-
blast growth factor (bFGF), tumor necrosis factor 
 
a
 
, and
vascular endothelial growth factor, vascular endothelial
cells (EC) reenter the cell cycle and upregulate proteolytic
activity to degrade the existing BM, facilitating their inva-
sion into stromal tissue. These vascular sprouts then syn-
thesize a new BM and undergo morphological reorganiza-
tion into mature quiescent, lumen-containing capillaries.
Proteolysis of the BM, along with enhanced vascular
permeability which accompanies angiogenesis, facilitates
an influx of serum proteins including vitronectin, fibronec-
tin, and fibrinogen, creating a provisional extracellular
matrix on which EC migrate. Although not typically ex-
pressed by quiescent resting EC, angiogenic EC express
high levels of integrin 
 
a
 
v
 
b
 
3, which can effectively bind this
provisional matrix (Brooks et al., 1994; for review see
Cheresh and Mecham, 1994). In fact, both matrix-degrad-
ing serine and metalloproteinases and integrin 
 
a
 
v
 
b
 
3 have
been shown to play essential roles in new vessel formation,
as inhibition of their respective activities will impair tu-
mor- or cytokine-mediated angiogenesis (Mignatti et al.,
1989; Brooks et al., 1994; Johnson et al., 1994; Min et al.,
1996). The mechanism by which angiogenic cytokines co-
ordinately upregulate expression of proteases and adhe-
sion molecules involved in angiogenesis however is not
known.
One class of transcriptional activators that have been
linked to extensive tissue remodeling are the homeobox
(Hox) genes. In addition to their role in embryonic devel-
opment, the 
 
Hox
 
 genes have been shown to play a signifi-
cant role in differentiation and gene expression in adult
tissues (Lawrence and Largman, 1992; Takeshita et al.,
1993; Savageau et al., 1995). Inappropriate Hox gene ex-
pression has also been linked to tumorigenic tissues
(Friedmann et al., 1994; Redline et al., 1994). 
 
Hox
 
 genes
are characterized by a highly conserved 180-bp DNA-
binding domain known as the homeodomain, which inter-
acts directly with DNA to activate transcription of genes
(Desplan et al., 1985). Putative target genes for Hox
DNA-binding proteins include other Hox genes and tran-
scription factors, cell adhesion molecules, extracellular
proteins, and growth factors (for reviews see Botas, 1993;
and Edelman and Jones, 1993; Immergluck et al., 1990;
Goomer et al., 1994; Taniguchi et al., 1995). Interestingly,
in the genome, Hox and integrin receptor gene families
colocalize in clusters, indicative of parallel, coordinate
evolution, further supporting a link between these groups
of genes associated with tissue patterning (Wang et al.,
1995).
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Given the dramatic changes in cell–extracellular matrix
interactions, EC morphology, and gene expression that oc-
cur during angiogenesis, we investigated expression of
 
Hox
 
 genes and their role in endothelial cell behavior.
 
Materials and Methods
 
Cells and Culture Conditions
 
Experiments were conducted using primary human umbilical vein endo-
thelial cells (HUVEC; Clonetics, San Diego, CA) or an immortalized HU-
VEC cell line (line 1998; American Type Culture Collection, Rockville,
MD). HUVECs were routinely cultured in M199 plus 20% FCS and
ECGS (Upstate Biotechnologies, Lake Placid, NY). The immortalized
1998 cell line was maintained in M199 plus 5% FCS. For experiments in
which bFGF was added, HUVECS were maintained in M199 plus 5%
FCS, while the 1998 cell line was maintained in M199 with 2% serum. Re-
combinant human bFGF was purchased from Upstate Biotechnologies,
and also kindly supplied by Dr. Judith Abraham (Scios Nova Inc., Moun-
tain View, CA). For experiments using basement membrane, 1 
 
3
 
 10
 
6
 
 cells
were seeded onto thick layers of Matrigel (Becton Dickinson, Bedford,
MA). Chick embryo fibroblast isolation and maintenance of the viral
packaging cell line Q4dh was performed as previously described (Stoker
and Bissell, 1988).
Transfection of immortalized HUVEC or Q4dh cell lines was per-
formed using calcium phosphate and stable transfectants selected using
800 or 400 
 
m
 
g/ml G418, respectively (Sigma Chemical Co., St. Louis, MO).
At least two independently selected pools of stably transfected cells were
used for subsequent analysis.
 
Isolation of HOX Genes Expressed in EC
 
RT-PCR of HOX genes was performed using total RNA from primary
HUVECs cultured in the presence or absence of BM. After reverse tran-
scription with oligo-dT primers (Gene Amp; Perkin Elmer, Norwalk, CT),
DNA was amplified using degenerate primers against the conserved ho-
meodomain sequences as described by Friedman et al. (1994): forward
primer 5
 
9
 
-GGAATTCCGARCTNGARAARGARTT-3
 
9
 
; and reverse
primer 5
 
9
 
-CCCAAGCTTRTTYTGRAACCADATYTT-3
 
9
 
. PCR reac-
tion conditions include initial denaturation for 2 min at 95
 
8
 
C followed by
35 cycles at 95, 55, and 72
 
8
 
C for 1 min each plus a final incubation for 10
min at 72
 
8
 
C. In some instances, samples were reamplified for an additional
25 cycles using similar reaction conditions. Final PCR products were
cloned into TA cloning vectors (Invitrogen, San Diego, CA) and positive
clones amplified and Hox sequences identified by the dideoxy sequencing
method of Sanger et al. (1977).
For quantitative PCR analysis of 
 
Hox D3
 
 mRNA, 1 
 
m
 
g of total RNA
was reverse transcribed using oligo-dT primers and amplified for 30 cycles
at 95, 60, and 72
 
8
 
C with 
 
Hox D3
 
 primers spanning a coding region to elim-
inate amplification of possible contaminating genomic DNA (forward
primer [bp 1682–1705] 5
 
9
 
-TGGTCTGAACTCAGAGCAGCAGC-3
 
9
 
 and
reverse primer [bp 3962–3938] 5
 
9
 
-TCATGCGCCGGTTCTGGAACCA-
3
 
9
 
). This yielded the predicted 415-bp PCR product, which was confirmed
by DNA sequencing. To normalize for amounts of starting RNA, equal
volumes of reaction mixtures were amplified for 35 cycles at 95, 60, and
72
 
8
 
C for 1 min each using primers for human GAPDH; forward primer
(bp 212–236) 5
 
9
 
-CCACCCATGGCAAATTCCATGGCA-3
 
9
 
; and reverse
primer (bp 787–811) 5
 
9
 
-TCTAGACGGCAGGTCAGGTCCACC-3
 
9
 
;
(Stratagene, La Jolla, CA). PCR products were visualized and isolated by
running through 2% agarose gels containing 1 
 
m
 
g/ml ethidium bromide.
 
Construction of Expression Vectors
 
Human genomic Hox D3 DNA was a gift from Y. Taniguchi (Tokai
School of Medicine, Bohseidai, Isehara, Kanagawu, Japan). A full length
Hox D3 cDNA was constructed by inserting the 415-bp PCR product,
generated as described above, between the Pst I site (bp 1899) and the
EcoRI site (bp 3853) in the genomic 
 
Hox D3.
 
 Expression vectors were
constructed by inserting either the genomic or Hox D3 cDNA between
the KpnI and BamHI sites of pcDNA3 mammalian expression vector (In-
vitrogen). Antisense expression vectors were constructed by inserting the
genomic DNA between the BamHI and HindIII sites of the pcDNA3 in
the antisense orientation. For controls, cells were transfected with empty
pcDNA3 vectors.
Chicken retroviral expression vectors were constructed by inserting ei-
ther the Hox D3 genomic DNA or cDNA between the ClaI and BamHI
sites of the replication-defective retroviral vector CK (a gift from B.
Vennstrom, European Molecular Biology Laboratory, Heidelberg, Ger-
many). These vectors were then stably transfected into the packing cell
line Q4dh to generate infectious virus (Stoker and Bissell, 1988). Produc-
tion of infectious retrovirus was monitored by infecting chick embryo fi-
broblasts with supernatants from cultures of stably transfected packing
cells as described by Stoker and Bissell (1988).
 
RNA Isolation and Northern Blot Analysis
 
Total RNA was extracted using the Quick-Prep Kit (Qiagen, Santa Clara,
CA). For cells cultured on BM, cells were first detached from Matrigel us-
ing Matripserse (Becton Dickinson) and RNA isolated as described
above. 10 or 20 
 
m
 
g total RNA was run through 1% agarose formaldehyde
gels and transferred to Hybond-N membranes (Amersham Intl., Arling-
ton Heights, IL) according to standard procedures. Membranes were hy-
bridized using [
 
32
 
P]dCTP-labeled cDNA probes and exposed to Kodak
X-Omat film at 
 
2
 
70
 
8
 
C. cDNA probes for human 
 
b
 
3 and 
 
b
 
5 integrin were
from E. Filardo (Brown University, Providence, RI). cDNA probe for hu-
man urokinase plasminogen activator (uPA) was kindly provided by Gra-
ham Parry (The Scripps Research Institute, La Jolla, CA).
 
Western Blots
 
Cultured cells were lysed in buffer containing 1 M NaCl, 10 mM Tris, pH
7.5, 1% Triton X-100 and aprotinin, PMSF, and leupeptin. Total protein
concentration was determined using the BCA reagent kit (Pierce, Rock-
ford, IL), and a total of 10 
 
m
 
g was run on 10 or 12% SDS-PAGE under re-
ducing conditions. Gels were transferred to Immobilon nylon membranes
(Millipore, Bedford, MA) and blocked in TBS plus 5% milk proteins.
Blots were probed using either 1:200 dilution of monoclonal anti–human
cyclin D1 (sc-246; Santa Cruz Biotechnologies, Santa Cruz, CA) or 10 
 
m
 
g/
ml polyclonal rabbit antihuman 
 
b
 
3 integrin (AP-3) followed by a 1:1,000
dilution of either goat anti–rabbit or goat anti–mouse HRP (Biosource In-
ternational, Camarillo, CA) and visualized by chemiluminescence (ECL;
Amersham Intl.).
 
Adhesion Assays
 
Cells were removed by incubation with versene (0.5 M EDTA in PBS, pH
7.4) and resuspended in FBM media (Clonetics Corp., San Diego, CA)
supplemented with 0.2 M MnCl
 
2
 
. A total of 5 
 
3
 
 10
 
5
 
 cells was seeded into
each well of 24-well culture dishes (Costar Corp., Cambridge, MA) that
had been previously coated for 1 h at 37
 
8
 
C with either heat-denatured
BSA (1%) or 10 
 
m
 
g/ml human fibrinogen (Sigma Chemical Co.). In some
cases 25 
 
m
 
g/ml of a function blocking anti–human 
 
a
 
v
 
b
 
3 integrin (mAb
LM609) were added along with cells. After extensive washing, cells were
fixed in 2% ethanol and stained with 1% crystal violet. The number of ad-
herent cells was quantitated by absorbance at 600 nm.
 
BrdU Incorporation
 
To determine the effect of Hox D3 on cell proliferation, the rate of DNA
synthesis was established by measuring BrdU incorporation in control and
EC transfected with either Hox D3 or Hox D3 antisense expression vec-
tors. After incubation for 4 or 12 h with 10 
 
m
 
M BrdU, cells were fixed with
70% ethanol and stained with an anti-BrdU kit (Boehringer Mannheim,
Indianapolis, IN) followed by staining with 0.5 
 
m
 
g/ml DAPI (4,6 diami-
dino-2-phenylindole; Sigma Chemical Co.). The percentage of BrdU-posi-
tive nuclei was determined by counting at least six different fields in each
of the cell types tested.
 
Chick Chorioallantoic Membrane Assay
 
All assays were performed in 10-d-old pathogen-free embryos (SPAFAS).
Briefly, the chorioallantoic membranes (CAMs) were prepared as previ-
ously described by Brooks et al. (1994). Q4dh virus-producing cells were
trypsinized, and a total of 5 
 
3
 
 10
 
6
 
 cells were resuspended in 25 
 
m
 
l serum-
free M199 and seeded onto the membranes and embryos incubated at
39
 
8
 
C. After 3 d, CAMs were harvested by washing in PBS and fixed for 30
min in 2% paraformaldehyde followed by washing in 0.1 M glycine/PBS.
CAMs were embedded into embedding medium (OCT; Miles, Elkhardt,
IN), flash frozen in liquid nitrogen, and stored at 
 
2
 
80
 
8
 
C. 5-
 
m
 
m sections
were prepared and mounted on slides for immunohistochemistry. 
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Immunohistochemistry
 
Sections were briefly fixed in 100% acetone and equilibrated with PBS.
After blocking in PBS plus 5% BSA, sections were incubated with either 5
 
m
 
g/ml monoclonal antihuman 
 
a
 
v
 
b
 
3 (LM609) or a 1:1,000 dilution of poly-
clonal rabbit anti–human von Willebrand Factor (BioGenex, San Ramon,
CA). Goat anti–mouse-rhodamine or goat anti–rabbit-FITC (Biosource
International, Camarillo, CA) were used as secondary antibodies. Sec-
tions were subsequently mounted using Fluoromount (Southern Biotech-
nologies, Birmingham, AL).
 
In Situ Hybridization
 
Hox D3
 
 sense and antisense digoxigenin-labeled RNA probes were gener-
ated by linearizing the vector pCR II (Invitrogen) containing the 415-bp
Hox D3 cDNA (generated by RT-PCR described above) and incubating
with T7 or SP6 RNA polymerase and digoxigenin-conjugated dUTP (Ge-
nius; Boehringer Mannheim). In situ hybridization was performed on 5-
 
m
 
m
cryosections mounted on siliconized slides (Sigma Chemical Co.). Sec-
tions were fixed in 4% paraformaldehyde for 20 min and dehydrated in
30, 70, and 100% ethanol for 2 min each and hybridized overnight at 45
 
8
 
C
with 800 ng/ml of 
 
Hox D3
 
 riboprobes in 50% formamide, 10% dextran
sulfate, 1% blocking reagent (DIG nucleic acid detection kit; Boehringer
Mannheim), 300 
 
m
 
g/ml yeast tRNA (Sigma Chemical Co.), 3 mM NaCl, 10
mM Tris, pH 7.5, and 1 mM EDTA. After washing in 0.2
 
3
 
 SSPE at 50
 
8
 
C
for 2 h, sections were incubated overnight with a 1:500 dilution of HRP-
conjugated antibodies against digoxigenin and color developed using
NBT/BCIP (DIG nucleic acid detection Kit; Boehringer Mannheim).
Nonspecific hybridization was assessed using Hox D3 sense riboprobes.
 
Results
 
Hox Gene Expression and the Angiogenic
Phenotype of EC
 
EC cultured on basement membrane adopt a distinct mor-
phology reminiscent of capillaries in vivo (Fig. 1 
 
A
 
, 
 
1
 
BM
 
), withdraw from the cell cycle, and cease DNA syn-
thesis within 24 h (Kubota et al., 1988). This “differenti-
ated phenotype” contrasts the characteristic cobblestone
morphology associated with proliferating EC cultured in
the absence of BM (Fig. 1 
 
A
 
, 
 
2
 
BM). RT-PCR of mRNA
from cultured EC detected the presence of a number of
 
Hox
 
 gene mRNA’s including 
 
Hox
 
 A4, B3, B4, B5, and D3
(data not shown). Previous studies have linked Hox D3
with expression of 
 
b
 
3 integrin mRNA in erythroleukemia
cells (Tanaguchi et al., 1995). This 
 
b
 
3 subunit is common
to integrin 
 
a
 
v
 
b
 
3, which is highly expressed by angiogenic
EC (Brooks et al., 1994), and prompted us to examine
whether 
 
Hox D3
 
 expression was related to the expression
of 
 
a
 
v
 
b
 
3 on EC. We therefore performed quantitative
RT-PCR analysis of EC cultured in the presence (
 
1
 
) or
absence (
 
2
 
) of BM for 36 h. As shown in Fig. 1 
 
B
 
, 
 
Hox D3
 
expression was detected in proliferating EC but not in qui-
escent EC cultured on BM. Northern and Western blot
analysis also shows that high levels of both 
 
b
 
3 integrin
mRNA and protein were preferentially expressed by pro-
liferating EC. Similarly, uPA mRNA was also highly ex-
pressed in proliferating but not quiescent EC (Fig. 1 
 
C
 
).
Thus, while quiescent EC do not express detectable levels
of 
 
Hox D3
 
, 
 
b
 
3 integrin, or uPA mRNA, EC in the absence
of BM express 
 
Hox D3
 
 and genes associated with the an-
giogenic phenotype.
 
Hox D3 Induces 
 
b
 
3 Integrin and uPA mRNA but Does 
Not Influence EC Proliferation
 
To determine whether the expression of 
 
Hox D3 influ-
ences expression of genes associated with the angiogenic
phenotype of EC, a HUVEC cell line was stably trans-
fected with a Hox D3 expression vector. Northern blot
analysis shows that HUVECs overexpressing Hox D3
have significantly higher levels of steady-state b3 integrin
and uPA mRNA levels as compared to cells transfected
with control vectors. In contrast, mRNA encoding integrin
b5, which is not upreglated during angiogenesis, did not
differ in control or Hox D3-transfected cells (Fig. 2 A). To
establish whether Hox D3 was required for EC expression
of b3 integrin and uPA, HUVECs were stably transfected
with Hox D3 antisense expression vectors. Compared to
control-transfected cells, baseline levels of both b3 inte-
grin and uPA mRNA were significantly reduced in cells
expressing Hox D3 antisense. In contrast, levels of b5 inte-
grin mRNA were not influenced by expression of Hox D3
antisense (Fig. 2 B).
The Hox D3-mediated changes in expression of integrin
b3 mRNA also resulted in corresponding changes in sur-
face expression of functional avb3 integrin. We compared
the ability of EC overexpressing Hox D3 or antisense
against  Hox D3 to adhere to fibrinogen, a ligand for avb3
on endothelial cells (Cheresh et al., 1989). EC expressing
antisense against Hox D3 displayed significantly reduced
Figure 1. Expression of Hox D3, b3 integrin, and uPA in quies-
cent and proliferative EC. (A) Morphology of HUVEC cultured
in the presence (1) or absence (2) of reconstituted BM after 24 h
in M199 containing 5% FCS. (B) RT-PCR of 1 mg mRNA from
HUVEC cultured for 48 h with (1) or without (2) reconstituted
BM using primers for Hox D3 or GAPDH. (C) Western (top)
and Northern (bottom) blot analysis of integrin b3 expression in
HUVEC cultured in the presence (1) or absence (2) of BM for
48 h. Northern blots were reprobed for uPA mRNA expression.
The bottom panel shows ethidium bromide staining of total RNA
loaded in the corresponding gel.The Journal of Cell Biology, Volume 139, 1997 260
capacity to adhere to fibrinogen, compared to control cells
(Fig. 3 A), whereas overexpressing Hox D3 increased EC
adhesion to fibrinogen (Fig. 3 A). Treatment of cells with
LM609, a function-blocking antibody against avb3 (Cheresh,
1987), resulted in a complete inhibition of the fibrinogen-
mediated attachment of these cells (data not shown).
Thus,  Hox D3 regulates the functional expression of avb3
on endothelial cells.
The fact that angiogenesis is often accompanied by EC
proliferation prompted us to examine whether Hox D3
also influenced the rate of EC growth. We therefore com-
pared DNA synthesis, as determined by BrdU incorpora-
tion, in control EC and EC transfected with Hox D3 or
Hox D3 antisense expression vectors. In contrast to the
Hox D3-induced changes in expression of integrin b3 and
uPA described above, no differences in DNA synthesis
were observed between control EC, EC expressing Hox
D3, or antisense against Hox D3 (Fig. 3 B). Therefore,
while  Hox D3 antisense can influence the expression of in-
tegrin avb3 and uPA in EC it apparently does not directly
influence the proliferation of these cells.
Hox D3 Mediates bFGF-induced Expression of b3 
Integrin and uPA but Not Cyclin D1 in EC
The angiogenic cytokine bFGF leads to expression of both
uPA and b3 integrin in EC, which subsequently contribute
to the invasive properties of EC during the early stages of
angiogenesis (Moscatelli et al., 1985; Enenstein et al.,
1992; Brooks et al., 1994; Sepp et al., 1994). To determine
whether Hox D3 could influence the bFGF-mediated in-
duction of integrin avb3 and uPA, EC were made quies-
cent by culturing on BM and treating with or without
bFGF and analyzed for expression of mRNA encoding
these proteins. As shown in Fig. 4, exposure of HUVECs
to bFGF led to an increase in Hox D3 expression after 8 h,
which was accompanied by increased b3 integrin and uPA
steady-state mRNA levels by 24 h (Fig. 4, A and B). In
contrast, in EC expressing antisense against Hox D3, the
ability of bFGF to induce high levels of expression of b3
integrin and uPA mRNA expression was attenuated. Im-
portantly, integrin b5 mRNA was not altered in either the
control or antisense-transfected cells in the presence or
absence of bFGF (Fig. 4, A and B).
Figure 2. Influence of Hox D3 on b3 integrin and uPA expres-
sion in endothelial cells. (A) Northern blot analysis of b3 inte-
grin, b5 integrin, uPA, and Hox D3 mRNA levels from 20 mg to-
tal RNA from immortalized HUVEC stably transfected with
control (C) or Hox D3 (Hox) expression vectors. The lower panel
shows ethidium bromide staining of total RNA loaded for each
sample in the corresponding gel. (B) Northern blot analysis of b3
integrin, b5 integrin, and uPA mRNA expression levels from im-
mortalized HUVECS transfected with control (C) or antisense
expression vectors for Hox D3 (AS). RNA (20 mg) from each
sample was loaded, and total RNA was visualized by ethidium
bromide staining of the corresponding gel. The lower box shows
RT-PCR of 1 mg total RNA from cells transfected with control
(C) or antisense expression vectors against Hox D3 (AS) using
primers for Hox D3 or GAPDH.
Figure 3. Effects of Hox D3 sense and antisense expression on
EC adhesion and proliferation. (A) Adhesion to microtitre wells
coated with 10 mg/ml fibrinogen by EC transfected with Hox D3
sense (j) or antisense ( ) expression vectors. Adhesion after 30
min was assessed by absorbance at 600 nm and expressed as a
percentage of adhesion displayed by control-transfected EC (n 5
3). *P , 0.05. (B) BrdU incorporation in control-transfected EC
(h), Hox D3-overexpressing cells (j), or cells expressing anti-
sense against Hox D3 ( ). Cells were labeled for 4 or 12 h with
10 mM BrdU. The percentage of cells staining positive for BrdU
was assessed by counting at least six different fields containing a
total of at least 400 cells each.Boudreau et al. Hox D3 and the Angiogenic Phenotype 261
Although bFGF can also act as an endothelial cell mito-
gen, expressing Hox D3 antisense had no effect on bFGF’s
ability to induce cyclin D1 in EC (Fig. 4 C). Thus Hox D3
appears to mediate bFGF-induced expression of b3 inte-
grin and uPA but does not directly influence endothelial
cell cycle progression. This is consistent with the observa-
tion that Hox D3 antisense had no effect on EC prolifera-
tion (Fig. 3 B). These findings indicate that Hox D3 ap-
pears to influence EC genes important for invasion but not
proliferation.
Sustained Expression of Hox D3
In Vivo Results in Vascular Malformations and
Development of Endotheliomas
During the late stages of angiogenesis, integrin avb3 and
uPA are down regulated as EC reestablish an intact BM
and form a lumen, suggesting that Hox D3 may be re-
quired only during the initial stages of angiogenesis. Main-
taining expression of Hox D3 therefore might be expected
to prolong expression of an invasive phenotype and inter-
fere with normal vascular maturation and/or remodelling.
To test this possibility, we constructed replication-defec-
tive avian retroviral vectors designed to constitutively ex-
press human Hox D3 in vivo. Transfection of a trans-
formed viral packaging cell line Q4dh with Hox D3 proviral
vectors yielded a retrovirus capable of infecting proliferat-
ing embryonic chick cells and driving expression of human
Hox D3 in these cells. When grafted onto 10-d chick em-
bryo CAM’s, transformed virus-producing Q4dh cells gen-
erate solid tumors in these animals. The continued produc-
tion of infectious virus leads to infection of adjacent,
proliferating cells including tumor-associated EC. As shown
in Fig. 5 A, maintenance of Hox D3 expression in these tis-
sues caused blood vessel malformations, reminiscent of
endotheliomas, which appeared as abnormal capillary-like
structures several times greater in diameter than large cap-
illaries and were filled with hematopoietic cells. A major-
ity of the EC and certain hematopoietic cells within these
endotheliomas remained positive for avb3, providing evi-
dence that Hox D3 was active in these tissues (Fig. 5 B).
To confirm the presence of Hox D3 in these vascular struc-
tures, we performed in situ hybridization using probes that
detect retrovirally produced human Hox D3 but do not de-
tect endogenous chick Hox genes. Retroviral-mediated Hox
D3 expression was observed in a wide variety of tissues in-
cluding epithelium, connective tissue, hematopoietic cells,
and endothelial cells (Fig. 5 C). In contrast to the wide-
spread viral infection and expression of Hox D3, avb3 in-
tegrin was only detected in EC and some hematopoietic
cells, suggesting this expression was highly specific.
These vascular malformations or endotheliomas ulti-
mately resulted in the formation of large hemorrhagic zones
within the tumors generated by 15/18 Hox D3-infected em-
bryos, but was not observed in tumors of the control em-
bryos (Fig. 6, A and B). H&E staining of sectioned Hox
D3-infected tissue showed large endothelial-lined cysts filled
with hematopoietic cells, many of which had hemorrhaged
(Fig. 6 D). In contrast, tumors producing control virus
showed normal tumor-induced angiogenesis (Fig. 6 C). These
findings not only establish a role for Hox D3 in EC func-
tion but also emphasize the requirement for tightly regulated
expression of Hox D3 during the early events of angiogenesis.
Discussion
During embryonic development, normal tissue patterning
depends upon temporally and spatially restricted expres-
sion of Hox genes. Evidence is presented in this report
that patterning of the vasculature during angiogenesis is
affected by expression of the Hox D3 homeobox gene in
EC. We show that quiescent EC in contact with a BM ex-
press minimal levels of Hox D3, integrin avb3, and uPA.
However, exposure of EC to the angiogenic cytokine
bFGF leads to increased levels of Hox D3, resulting in the
functional expression of the angiogenic-promoting genes
integrin b3 and uPA in these cells.
Our findings that prolonged expression of Hox D3 re-
sults in abnormal vascular morphology also emphasizes
Figure 4. Hox D3 mediates bFGF-induced expression of b3 integrin and uPA. (A) RT-PCR of 1 mg total RNA from HUVEC 24 h after
treatment with 20 ng/ml bFGF (1bFGF) using primers for Hox D3 or GAPDH. (B) Northern blot analysis of b3 integrin, b5 integrin,
and uPA mRNA levels in HUVEC transfected with control plasmid (C) or antisense against Hox D3 (AS) after 24 h with (1) or with-
out (2) addition of 20 ng/ml bFGF. (C) Western blot of cyclin D1 in immortalized HUVEC transfected with control or antisense against
Hox D3. After 24 h in serum-free M199, samples were collected at 2, 4, and 8 h after addition of 20 ng/ml bFGF. 10 mg total cell lysate
from each time point was separated on 12% SDS-PAGE, transferred to nylon membranes, and probed with a polyclonal antibody
against human cyclin D1.The Journal of Cell Biology, Volume 139, 1997 262
the requirement for tightly regulated expression of Hox
genes in EC. Previous studies have linked sustained ex-
pression of angiogenic mediators, including bFGF and
uPA with vascular tumors (Takahashi et al., 1994; Hatva et
al., 1996; Kraling et al., 1996). In vivo, transgenic mice ex-
pressing polyoma middle T oncogene develop endothelial
tumors, and in culture, these transformed EC form cystic
vascular structures reminiscent of endothelioma, a pheno-
type that can be reversed by inhibiting uPA activity (Bautch
et al., 1987; Montesano et al., 1990). In addition, embry-
onic chick cells infected with v-src, a downstream effector
of FGF, show elevated uPA activity, and v-src infection of
chick endothelial cells in vivo results in endotheliomas
(Sullivan and Quigley, 1986; Stoker et al., 1990). Thus,
while increased uPA activity is involved in normal capil-
lary remodeling, chronic expression driven by Hox D3
would be expected to prevent EC from establishing base-
ment membranes, forming patent vessels with lumens and
resuming a quiescent, differentiated phenotype. Further-
more, the sustained expression of integrin avb3 provides
the necessary means for EC to adhere, migrate, and sur-
vive in this angiogenic environment and thereby may en-
hance the activity of matrix-degrading serine and metallo-
proteinases, which interact with this integrin (Brooks et
al., 1996; Strömblad et al., 1996).
Previous studies have linked FGF to the induction of
Hox D genes during embryonic limb development, al-
though the precise targets of Hox D gene activity have not
been identified (Duprez et al., 1996). In this report it is ap-
parent that Hox D3 induction of integrin avb3 is tissue
specific, since this integrin was not detected in epithelial
tissues expressing human Hox D3. In fact, endogenous
Figure 6. Effect of retroviral-mediated expression
of Hox D3 in chick embryos. (A and B) Morphol-
ogy of tumors generated 3 d after grafting of QT6
cells producing control or Hox D3-expressing ret-
rovirus onto 10 d chick CAMs. (C and D) H&E
staining in tissue cross-sections from tumors (t)
and vasculature produced by cells shedding con-
trol or Hox D3-expressing retrovirus. Note the
large hemorrhagic region containing hematopoi-
etic cells (h) adjacent to tumor tissue in the Hox
D3-infected tissue. Bar, 50 mm.
Figure 5. Colocalization of
Hox D3 and avb3 integrin in
endotheliomas in vivo. (A)
H&E-stained cross-section
of tissue infected by Hox D3-
expressing retrovirus shows
an abnormally large capil-
lary-like structure filled with
erythrocytes. (B) Immuno-
fluorescent staining with
LM609 against avb3 in the
corresponding serial section
shows strong positive stain-
ing in both the endothelial
component (ec) of this vascu-
lar structure and in hemato-
poietic cells (h) contained
within. (C) In situ hybridiza-
tion of retrovirally expressed
Hox D3 in corresponding se-
rial section showing wide-
spread expression in epithe-
lium (ep), endothelial cells
(ec), connective tissue (c),
and hematopoietic cells (h).
(D) Control in situ hybridiza-
tion in a serial section per-
formed with a sense ribo-
probe for Hox D3. Bar, 20 mm.Boudreau et al. Hox D3 and the Angiogenic Phenotype 263
Hox D3 is expressed in human skin epithelium, yet this tis-
sue does not express avb3 (Detmer et al., 1993; Brooks et
al., 1994; Brown et al., 1994; Gailit et al., 1994). We also
observed that quiescent vessels in the skin do not express
Hox D3 (Boudreau, N., unpublished observations). How-
ever, EC and certain hematopoietic cells infected with
Hox D3-expressing retrovirus subsequently stained posi-
tively for avb3. Hox D3 has previously been shown to in-
duce expression of the b3 subunit of the aIIbb3 platelet
adhesion receptor in cultured human erythroleukemia
cells which can be induced to differentiate to erythroid
cells (Taniguchi et al., 1995). Thus, the ability of Hox D3
to mediate expression of the b3 integrin subunit may be
restricted to cells of the hematopoietic/angioblast lineage
which arise from common blood islands during embryo-
genesis (Risau, 1995).
We have also shown that Hox D3 antisense blocks the
bFGF-induced expression of integrin b3 and uPA mRNA,
yet has no effect on bFGF-induced expression of cyclin D1
in these cells. Furthermore, we have shown that Hox D3
does not directly influence the rate of cell proliferation,
and together these results suggest that these aspects of an-
giogenesis are differentially regulated. These observations
are also supported by studies showing Hox D3 overexpres-
sion had no effect on cell proliferation (Taniguchi et al.,
1995). Therefore in EC, Hox D3 appears to selectively
regulate the expression of genes that contribute to extra-
cellular matrix remodeling during angiogenesis.
Although both the integrin b3 and uPA promoters con-
tain several potential Hox-binding consensus sequences,
the complex relationship between Hox genes makes it dif-
ficult to predict whether Hox D3 acts alone or in combina-
tion with sequentially activated Hox genes to induce ex-
pression of these angiogenic effectors. For example,
studies with compound mutants of Hox D3 and A3, sug-
gests that paralogous Hox genes act in a synergistic man-
ner to influence tissue patterning (Condie and Capecchi,
1994). Similarly, activation or inhibition of the paralogous
Hox B3 gene, which is also expressed in EC, modifies ex-
pression of several other Hox genes including D3 (Faiella
et al., 1994). Nonetheless, in EC, expression of Hox D3 is
sufficient to convert quiescent EC to an angiogenic/inva-
sive state. This is supported by the observation that Hox
D3 antisense prevents bFGF-mediated expression of both
b3 integrin and uPA in these cells. Our findings also reveal
that temporally restricted expression of Hox D3 is re-
quired for normal angiogenesis since prolonged expres-
sion of Hox D3 maintains the angiogenic/invasive EC phe-
notype, thereby disrupting normal vascular remodeling.
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